Related Experiment Video
Updated: Apr 30, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021
Fumaric acid esters in psoriasis and multiple sclerosis
1Department of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale, Lugano, Switzerland.
Abstract:
Fumaric acid esters (FAEs) are effective in patients with moderate to severe psoriasis. Recent studies also report the efficacy of one FAE component, dimethylfumarate, in relapsing forms of multiple sclerosis (MS). We describe the case of a patient with MS who developed severe plaque psoriasis during interferon-β-1a treatment for MS. The psoriasis was unresponsive to usual topical treatments and phototherapy. The patient was started on FAE 720 mg daily, with complete remission of the psoriatic lesions and neurological stabilization at follow-up at 24 months. Our case suggests that FAEs could represent a therapeutic option for patients with MS who develop plaque psoriasis following exposure to immune-modulating agents.
Insights
Fumaric acid esters (FAEs) effectively treated severe plaque psoriasis in a multiple sclerosis (MS) patient unresponsive to other therapies. This suggests FAEs may benefit MS patients with treatment-induced psoriasis.
Area of Science:
- Dermatology and Neurology
- Immunomodulatory Therapies
Background:
- Psoriasis and multiple sclerosis (MS) are chronic inflammatory conditions.
- Fumaric acid esters (FAEs) and dimethylfumarate show efficacy in psoriasis and MS, respectively.
- Immune-modulating agents, like interferon-β-1a, can induce or exacerbate psoriasis.
Observation:
- A patient with MS developed severe plaque psoriasis during interferon-β-1a therapy.
- The patient's psoriasis was refractory to topical treatments and phototherapy.
- Dimethylfumarate (a component of FAEs) is used for relapsing MS.
Findings:
- The patient received FAEs at 720 mg daily.
- Complete remission of psoriatic lesions was observed.
- Neurological stabilization was maintained over 24 months of follow-up.
Implications:
- FAEs may be a viable treatment option for plaque psoriasis in MS patients.
- This approach could be particularly useful for psoriasis induced by immune-modulating agents.
- Further research into FAEs for managing comorbidities in MS is warranted.
Related Concept Videos
Multiple Sclerosis l: Introduction
Carboxylic Acids to Esters: Acid-Catalyzed (Fischer) Esterification Overview
Carboxylic Acids to Esters: Acid-Catalyzed (Fischer) Esterification Mechanism
Drugs for Treatment of Ulcerative Colitis in IBD
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...